US FDA to phase out animal testing in drug development
By Thomson ReutersApr 10, 2025 | 3:07 PM
(Reuters) – The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal antibody therapies and other drugs with “human-relevant methods,” including the use of AI-based models.
(Reporting by Mariam Sunny in Bengaluru; Editing by Alan Barona)
For the health and safety of everyone, our offices are temporarily closed to the public. If you have won a prize from us we will be mailing it to you or will contact you with specific information needed to redeem your prize. Feel free to call us with questions during weekday business hours at 715-842-1672.
